Abbott Laboratories ( ABT) - Key Metrics
ABT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.56 | $1.02 | ? | ? |
| 2025Q3 | $6.50 | $0.94 | $1.59 | $1.31 |
| 2025Q2 | $6.40 | $1.02 | $1.18 | $0.89 |
| 2025Q1 | $5.93 | $0.76 | $0.81 | $0.53 |
ABT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 58.04% | 30.81 |
| 2025Q3 | 62.71% | 35.62 |
| 2025Q2 | 57.84% | 33.27 |
| 2025Q1 | 77.43% | 43.73 |
ABT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 1.20% | 0.47% |
| 2025Q3 | 0.98% | 0.44% |
| 2025Q2 | 0.65% | 0.43% |
| 2025Q1 | 0.40% | 0.44% |
ABT
List: Contenders
Price: $90.73
Dividend Yield: 2.71%
Forward Dividend Yield: 2.78%
Payout Ratio: 69.40%
Dividend Per Share: 2.52 USD
Earnings Per Share: 3.57 USD
P/E Ratio: 25.69
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 5.1 million
Ebitda: 1.7 billionMarket Capitalization: 157.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 44
DGR3: 7.41%
DGR5: 10.99%
DGR10: 9.59%
DGR20: 4.31%